Empagliflozin vs Remimazolam Besylate
Empagliflozin vs Remimazolam Besylate: Overview
This comparison examines the pharmacological differences between Empagliflozin and Remimazolam Besylate.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7.
Molecular Weight: Empagliflozin β 450.9100 g/mol.
Type: Empagliflozin β Small molecule; Remimazolam Besylate β Small molecule.